Annual CFF
$186.58 M
+$143.72 M+335.34%
December 31, 2024
Summary
- As of March 12, 2025, AVBP annual cash flow from financing activities is $186.58 million, with the most recent change of +$143.72 million (+335.34%) on December 31, 2024.
- AVBP annual CFF is now at all-time high.
Performance
AVBP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$55.00 K
-$476.00 K-89.64%
December 31, 2024
Summary
- As of March 12, 2025, AVBP quarterly cash flow from financing activities is $55.00 thousand, with the most recent change of -$476.00 thousand (-89.64%) on December 31, 2024.
- Over the past year, AVBP quarterly CFF has dropped by -$308.00 thousand (-84.85%).
- AVBP quarterly CFF is now -99.97% below its all-time high of $185.63 million, reached on March 31, 2024.
Performance
AVBP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$186.58 M
+$1.11 M+0.60%
December 31, 2024
Summary
- As of March 12, 2025, AVBP TTM cash flow from financing activities is $186.58 million, with the most recent change of +$1.11 million (+0.60%) on December 31, 2024.
- Over the past year, AVBP TTM CFF has increased by +$2.68 million (+1.46%).
- AVBP TTM CFF is now at all-time high.
Performance
AVBP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AVBP Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +335.3% | -84.8% | +1.5% |
| 3 y3 years | - | -84.8% | +1.5% |
| 5 y5 years | - | -84.8% | +1.5% |
AVBP Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +335.3% | -100.0% | +105.2% | at high | +335.3% |
| 5 y | 5-year | at high | +335.3% | -100.0% | +105.2% | at high | +335.3% |
| alltime | all time | at high | +335.3% | -100.0% | +105.2% | at high | +335.3% |
ArriVent BioPharma Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $186.58 M(+335.3%) | $55.00 K(-89.6%) | $186.58 M(+0.6%) |
| Sep 2024 | - | $531.00 K(+46.3%) | $185.47 M(+0.9%) |
| Jun 2024 | - | $363.00 K(-99.8%) | $183.91 M(+0.2%) |
| Mar 2024 | - | $185.63 M(<-9900.0%) | $183.52 M(+328.2%) |
| Dec 2023 | $42.86 M | -$1.06 M(+2.3%) | $42.86 M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$1.03 M(+5065.0%) | $43.92 M(-58.2%) |
| Jun 2023 | - | -$20.00 K(-100.0%) | $104.95 M(-0.0%) |
| Mar 2023 | - | $44.97 M(-25.1%) | $104.97 M(+74.9%) |
| Dec 2022 | $169.72 M | - | - |
| Sep 2022 | - | $60.00 M | $60.00 M |
FAQ
- What is ArriVent BioPharma annual cash flow from financing activities?
- What is the all time high annual CFF for ArriVent BioPharma?
- What is ArriVent BioPharma annual CFF year-on-year change?
- What is ArriVent BioPharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly CFF year-on-year change?
- What is ArriVent BioPharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for ArriVent BioPharma?
- What is ArriVent BioPharma TTM CFF year-on-year change?
What is ArriVent BioPharma annual cash flow from financing activities?
The current annual CFF of AVBP is $186.58 M
What is the all time high annual CFF for ArriVent BioPharma?
ArriVent BioPharma all-time high annual cash flow from financing activities is $186.58 M
What is ArriVent BioPharma annual CFF year-on-year change?
Over the past year, AVBP annual cash flow from financing activities has changed by +$143.72 M (+335.34%)
What is ArriVent BioPharma quarterly cash flow from financing activities?
The current quarterly CFF of AVBP is $55.00 K
What is the all time high quarterly CFF for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly cash flow from financing activities is $185.63 M
What is ArriVent BioPharma quarterly CFF year-on-year change?
Over the past year, AVBP quarterly cash flow from financing activities has changed by -$308.00 K (-84.85%)
What is ArriVent BioPharma TTM cash flow from financing activities?
The current TTM CFF of AVBP is $186.58 M
What is the all time high TTM CFF for ArriVent BioPharma?
ArriVent BioPharma all-time high TTM cash flow from financing activities is $186.58 M
What is ArriVent BioPharma TTM CFF year-on-year change?
Over the past year, AVBP TTM cash flow from financing activities has changed by +$2.68 M (+1.46%)